How to Present RNA-Seq Data to a Non-Specialist Audience

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-27

Quick Answer

• Present RNA-seq results through a narrative arc that starts with the biological question, moves to the key finding, and ends with the practical implication for the audience.
• Replace raw fold changes and adjusted p-values with visual summaries such as volcano plots, heatmaps, and pathway diagrams that highlight the most biologically meaningful genes.
• Acknowledge the limits of the analysis openly, including sample size, batch effects, and validation status, because transparency builds trust with non-specialist listeners.

At a Glance

Why RNA-Seq Presentations Fail With Non-Specialists

The gap between a bioinformatics analysis and a room of non-specialists is not about intelligence. It is about shared vocabulary. A researcher who has spent months working with count matrices, principal component plots, and gene ontology terms can forget that the audience has not lived inside that data. The result is a presentation that reads like a methods section read aloud, with slides full of gene identifiers and adjusted p-values that mean little to someone who has not run the pipeline themselves.

The core problem is that RNA-seq produces high-dimensional data. A single experiment can measure the expression of twenty thousand genes across dozens of samples. That volume of information cannot be conveyed in a twenty minute talk or a single poster. The researcher must decide what matters most and build the presentation around that decision. Without a clear narrative, the audience is left to sort through the noise themselves, which almost always ends in confusion or disengagement.

Another common failure is the assumption that more detail equals more credibility. In practice, the opposite is true for non-specialist audiences. When a presenter walks through every quality control metric and every normalization choice, the audience loses the thread of the biological story. The technical details are important for the methods section of a paper or for a specialist seminar, but they are not the message for a general audience.

The solution is not to dumb down the science. It is to translate the science into a form that respects the audience's time and background. That means choosing a small number of key findings, explaining them with relatable analogies, and using visuals that support the narrative instead of replace it. The goal is to make the audience feel that they understand what was done, why it was done, and what it means, without requiring them to become bioinformaticians.

Building a Narrative Framework for RNA-Seq Results

A narrative framework gives the audience a path through the data. Without one, a presentation becomes a sequence of disconnected slides. With one, each slide builds on the last and leads toward a conclusion that the audience can carry away.

Start With the Biological Question

Every RNA-seq experiment begins with a question. The question might be about how a disease changes gene expression in a tissue, how a treatment affects a pathway, or how two breeds of livestock differ in their response to heat stress. Whatever the question, it should be the first thing the audience hears.

State the question in plain language. Avoid jargon where possible. For example, instead of saying "we sought to characterize the transcriptomic response to lipopolysaccharide challenge in bovine mammary epithelial cells," say "we wanted to know which genes turn on when a cow's udder cells encounter a bacterial toxin." The second version conveys the same information but gives the audience a picture they can hold onto.

The question also sets the expectation for what the audience should listen for. If the question is about treatment response, the audience will listen for whether the treatment changed gene expression. If the question is about disease mechanism, the audience will listen for which pathways are involved. A clear question makes the rest of the presentation easier to follow.

Identify the Key Finding Before You Build the Slides

The key finding is the single most important result from the experiment. It might be that a specific pathway is activated, that a particular gene is consistently downregulated, or that the treatment produces no detectable change in the tissue studied. Whatever it is, identify it before you start building slides.

This step requires the researcher to step back from the full results table and ask what a non-specialist would most want to know. The answer is usually the finding that has the clearest connection to the original question. If the question was about treatment response, the key finding is whether the treatment worked at the molecular level. If the question was about disease mechanism, the key finding is which biological process is disrupted.

Once the key finding is identified, every slide should support it. Slides that do not support the key finding should be cut or moved to an appendix. This discipline keeps the presentation focused and prevents the audience from being distracted by interesting but tangential results.

End With the Implication for the Audience

The final part of the narrative is the implication. What does this finding mean for the audience? For a farmer, it might mean that a particular feed additive changes the expression of genes related to immune function. For a clinician, it might mean that a tumor subtype has a distinct expression signature that could guide treatment decisions. For a funder, it might mean that the project produced useful data that advances the field.

The implication should be stated directly and without overclaiming. RNA-seq is a powerful tool, but it measures RNA abundance, not protein activity or clinical outcome. The presentation should make clear what the data can and cannot support. This honesty is part of responsible research communication and aligns with the expectations of research integrity outlined in the Committee on Publication Ethics Core Practices.

Choosing the Right Visual Summaries

Visuals are the most powerful tool for communicating RNA-seq results to non-specialists. A well-designed figure can convey in seconds what would take minutes of spoken explanation. The challenge is choosing the right visual for the message and designing it so that it can be read without a legend the size of a paragraph.

Volcano Plots for Differential Expression

A volcano plot shows the relationship between the magnitude of change and the statistical significance for every gene in the experiment. The x-axis shows the log fold change, which is a measure of how much a gene's expression changed between conditions. The y-axis shows the statistical significance, usually as the negative log of the adjusted p-value. Genes that are both highly changed and highly significant appear in the upper corners of the plot.

For a non-specialist, the volcano plot can be explained as a map of the experiment's results. Genes in the upper right are strongly increased and statistically reliable. Genes in the upper left are strongly decreased and statistically reliable. Genes in the middle are either unchanged or not measured with enough confidence to draw conclusions.

The presenter should highlight a small number of genes on the plot and explain what those genes do. This turns an abstract scatter of points into a concrete story about specific biological players. Without this annotation, the volcano plot is just a cloud of dots.

Heatmaps for Sample and Gene Patterns

A heatmap shows the expression level of many genes across many samples, with colors representing expression intensity. Rows are usually genes and columns are usually samples. The heatmap can reveal patterns such as groups of samples that cluster together or groups of genes that behave similarly across conditions.

For non-specialists, the heatmap is best explained as a visual summary of the experiment's overall structure. If the samples cluster by treatment group, that is a strong visual message that the treatment has a consistent effect on gene expression. If the samples cluster by something unexpected, such as batch or animal, that is also important and should be acknowledged.

The presenter should not expect the audience to read individual gene names from a heatmap. Instead, the presenter should point to the overall pattern and then zoom in on a few genes of interest. This approach gives the audience the big picture and the specific detail without overwhelming them.

Pathway Diagrams for Biological Context

Pathway diagrams show how genes interact within a biological process. These diagrams can be powerful for non-specialists because they explain what the genes do instead of just how much they changed. A pathway diagram with the affected genes highlighted in color shows the audience which part of the biology is disrupted.

The presenter should choose a pathway that is directly relevant to the biological question. If the question is about immune response, the diagram might show the inflammatory signaling pathway. If the question is about metabolism, the diagram might show the relevant metabolic pathway. The presenter should walk through the diagram step by step, explaining what each highlighted gene does and why its change matters.

Pathway diagrams can become cluttered if too many genes are highlighted. The presenter should limit the highlight to the most important genes, usually the ones that are both significantly changed and biologically meaningful. This keeps the diagram readable and the message clear.

Practical Steps for Preparing Your Presentation

Preparing an RNA-seq presentation for a non-specialist audience requires a different workflow than preparing one for a specialist seminar. The following steps provide a practical path from raw results to a clear presentation.

Step 1: Define the Audience and Their Stake

Before building any slides, write down who the audience is and what they care about. A presentation to a farmers' cooperative is different from a presentation to a hospital research committee. The farmer wants to know whether the research affects animal health or production. The clinician wants to know whether the research affects patient care. The funder wants to know whether the money was well spent.

Write one sentence that describes the audience's stake in the research. This sentence will guide every decision about what to include and what to leave out. If a result does not connect to the audience's stake, it probably does not belong in the main presentation.

Step 2: Write the Narrative in Plain Language First

Before creating any figures, write the story of the experiment in plain language. Use short sentences and avoid technical terms. The narrative should have a beginning, a middle, and an end. The beginning states the question. The middle describes what was done and what was found. The end states the implication.

This written narrative becomes the script for the presentation. It also serves as a test of whether the story is clear. If the narrative cannot be written in plain language, the presenter does not yet understand the results well enough to present them.

Step 3: Select the Minimum Number of Figures

Choose the smallest number of figures that can tell the story. For most presentations, this will be between three and five figures. A typical set might include one figure showing the experimental design, one showing the overall pattern of expression, one showing the key differentially expressed genes, and one showing the pathway context.

Each figure should have a clear purpose that is stated in the slide title. The title should be a message, not a description. Instead of "Volcano plot of differentially expressed genes," the title should be "Treatment activates immune genes in mammary tissue." This forces the presenter to think about what the figure is actually showing.

Step 4: Annotate Every Figure for the Audience

Every figure should be annotated so that the audience knows what to look at and what it means. Annotations can include arrows pointing to key genes, boxes around important clusters, and short labels explaining what the audience is seeing. The annotation should be visible from the back of the room, which means using large fonts and high contrast colors.

The presenter should also prepare a spoken explanation for each figure that takes no more than thirty seconds. This explanation should state what the figure shows, why it matters, and how it connects to the overall narrative. If the explanation takes longer than thirty seconds, the figure is probably too complex or the presenter is trying to say too much.

Step 5: Rehearse With a Non-Specialist

The best test of a presentation is to rehearse it with someone who is not a specialist in the field. This person can be a colleague from another department, a student, or a friend. The rehearsal should be treated as a real presentation, with slides and timing.

After the rehearsal, ask the listener to explain back what they understood. This feedback reveals which parts of the presentation worked and which parts need revision. The presenter should revise the presentation based on this feedback, even if the revision means cutting slides that are personally interesting.

Records and Measurements for Presentation Quality

Presentations are not usually thought of as requiring records, but keeping track of what works and what does not can improve future presentations. The following records are useful for researchers who present RNA-seq data regularly.

Audience Feedback Log

After each presentation, record the questions that the audience asked. These questions reveal what the audience did not understand or what they wanted to know more about. Over time, a pattern of questions can identify recurring gaps in the presentation. For example, if every audience asks how the samples were collected, the presentation should include a brief description of sample collection.

The feedback log can be a simple spreadsheet with columns for the date, the audience, the questions asked, and any notes about what worked or did not work. This record is a practical tool for continuous improvement.

Figure Effectiveness Notes

Keep notes on which figures were most effective with non-specialist audiences. Some figures will consistently generate understanding and good questions. Others will consistently generate confusion. The notes should record what worked and what did not, along with any changes that were made to the figure.

These notes are especially valuable when preparing a new presentation on a different experiment. The researcher can start from the figures that are known to work and avoid the ones that are known to fail.

Presentation Timing Record

Record how long each section of the presentation actually takes. Most presenters underestimate how long they spend on the methods and overestimate how long they spend on the results. A timing record reveals these imbalances and helps the presenter allocate time to the parts of the presentation that matter most to the audience.

The timing record can be kept during the rehearsal or during the actual presentation. It is most useful when the presenter is preparing for a talk with a strict time limit, such as a conference presentation or a thesis defense.

Common Failure Patterns in RNA-Seq Presentations

Recognizing common failure patterns can help presenters avoid them. The following patterns appear frequently in presentations of RNA-seq data to non-specialist audiences.

The Gene List Dump

The presenter shows a table or list of dozens of differentially expressed genes, expecting the audience to be impressed by the volume of results. The audience, however, cannot process a list of gene names that mean nothing to them. The result is confusion and disengagement.

The fix is to select a small number of genes, usually three to five, that are most important to the story. Each gene should be explained in terms of what it does and why its change matters. The full gene list can be mentioned as available in the supplementary materials for those who want the detail.

The Methods Monologue

The presenter spends the first half of the talk walking through the RNA extraction, library preparation, sequencing platform, and bioinformatics pipeline. The audience, especially if they are not molecular biologists, loses interest before the results are shown.

The fix is to compress the methods into a single slide that shows the experimental workflow as a simple diagram. The presenter should mention the key steps in one or two sentences and then move to the results. Detailed methods belong in the paper, not in the presentation to a non-specialist audience.

The Unlabeled Figure

The presenter shows a complex figure, such as a principal component plot or a clustering dendrogram, without explaining what the axes mean or what the audience should look at. The audience stares at the figure without understanding it.

The fix is to annotate every figure with clear labels and to provide a spoken explanation that walks the audience through what they are seeing. The presenter should assume that the audience has never seen this type of figure before and should explain it accordingly.

The Overclaiming Conclusion

The presenter states that the RNA-seq results prove that a treatment works or that a disease mechanism is understood. This overclaiming ignores the limitations of RNA-seq, which measures RNA abundance and not protein activity or clinical outcome.

The fix is to state conclusions with appropriate caution. The presenter should say what the data show and what they do not show. This honesty is consistent with the expectations for transparent research reporting promoted by the EQUATOR Network and the NIH Data Management and Sharing Policy.

Limitations of RNA-Seq Data in Public Presentations

RNA-seq is a powerful technology, but it has limitations that presenters should acknowledge. Acknowledging these limitations does not weaken the presentation. It strengthens it by showing that the researcher understands the scope and boundaries of the evidence.

RNA Abundance Is Not Protein Activity

RNA-seq measures the abundance of RNA transcripts in a sample. It does not measure the amount of protein produced from those transcripts, nor does it measure the activity of those proteins. A gene can have high RNA expression and low protein activity due to post-transcriptional regulation. Presenters should avoid claiming that a change in RNA expression means a change in protein function.

This limitation is especially important when presenting to audiences who may act on the results, such as farmers deciding whether to change a feeding practice or clinicians considering a treatment approach. The presenter should state clearly that the RNA results are one piece of evidence and that additional studies are needed to confirm the biological effect.

Sample Composition Affects Results

RNA-seq results reflect the composition of the sample that was sequenced. If the sample contains multiple cell types, the expression profile is an average across those cell types. A change in expression could reflect a change in gene activity within a cell type or a change in the proportion of cell types in the sample.

This limitation is relevant for presentations to audiences who are familiar with the tissue being studied. A farmer who knows that a tissue sample contains both muscle and fat cells will want to know whether the expression change is happening in one cell type or both. The presenter should acknowledge this limitation and, if possible, describe any steps taken to address it, such as using purified cell populations or single-cell sequencing.

Statistical Significance Is Not Biological Importance

A gene can have a highly significant adjusted p-value and a large fold change and still be biologically unimportant. Statistical significance reflects the confidence in the measurement, not the biological relevance of the change. A gene that changes tenfold but has no known function in the tissue being studied may be less interesting than a gene that changes twofold and is known to be a key regulator.

Presenters should select genes for emphasis based on biological importance, beyond statistical significance. This selection requires the researcher to use their knowledge of the biology, which is exactly the expertise that a non-specialist audience is relying on.

Welfare and Safety Context for Animal Research Presentations

When RNA-seq data come from animal studies, the presentation should include appropriate context about animal welfare and research ethics. This context is important for audiences that include animal owners, farmers, and members of the public who care about animal welfare.

Describe the Animal Use Briefly and Transparently

The presentation should include a brief description of the animals used in the study, including the species, the number of animals, and the conditions under which they were housed. This description should be factual and transparent. It should not hide the use of animals, nor should it dwell on details that are not relevant to the audience.

For audiences of farmers and animal owners, the description of animal use should connect to the practical purpose of the research. If the research aims to improve animal health or production, the presenter should say so. This connection helps the audience understand why the research was worth doing.

State the Ethical Approvals and Standards

The presentation should state that the animal work was conducted under appropriate ethical approvals and in accordance with relevant standards. This statement is a matter of research integrity and is expected by audiences who are concerned about animal welfare.

The NIH Grants and Funding pages describe the expectations for research conduct that apply to NIH-funded projects, including those involving animals. Presenters should be prepared to describe the ethical framework for their animal work if asked.

Acknowledge the Limits of What the Data Can Say About Animal Welfare

RNA-seq data can reveal molecular changes in animal tissues, but they cannot directly measure animal welfare. A change in the expression of stress-related genes is not the same as observing that an animal is stressed. Presenters should avoid making claims about animal welfare that go beyond what the data can support.

This caution is especially important when presenting to animal owners who may be concerned about the welfare implications of a treatment or condition. The presenter should state what the molecular data show and what additional observations would be needed to draw conclusions about welfare.

Professional Escalation Criteria for Presenters

There are situations where a presenter should seek additional help or escalate a concern. The following criteria describe when to involve a supervisor, a statistician, or an ethics advisor.

When the Results Are Unclear

If the presenter cannot explain the key finding in plain language, the results may not be clear enough to present. This situation calls for a meeting with the research team to clarify the analysis before the presentation is built. Presenting unclear results to a non-specialist audience risks confusing them and damaging the credibility of the research.

When the Audience Includes Decision Makers

If the audience includes people who will make decisions based on the presentation, such as farmers deciding whether to adopt a practice or clinicians considering a treatment, the presenter should have the results reviewed by a colleague before the presentation. This review is a quality control step that can catch errors or overstatements before they reach the decision makers.

When the Research Involves Sensitive Topics

If the research involves topics that are sensitive for the audience, such as animal disease, euthanasia, or controversial treatments, the presenter should consult with the research team or an ethics advisor before the presentation. This consultation can help the presenter anticipate concerns and prepare appropriate responses.

When the Data Are Not Yet Published

If the data have not been through peer review, the presenter should be especially careful about the claims made in the presentation. Unpublished data are less certain than published data, and the presenter should communicate this uncertainty to the audience. The Committee on Publication Ethics Core Practices describe the expectations for responsible data sharing and reporting that apply throughout the research process.

Frequently Asked Questions

How do I explain a volcano plot to someone who has never seen one?

A volcano plot is a scatter plot where each dot is a gene. The horizontal position shows how much the gene changed between the two conditions being compared. The vertical position shows how confident we are in that change. Genes in the upper corners are both strongly changed and measured with high confidence. Point to a few of these genes and explain what they do.

What is the most common mistake researchers make when presenting RNA-seq data to non-specialists?

The most common mistake is showing too many genes and too much technical detail. The audience cannot process a list of hundreds of gene names, and they do not need to know every normalization step. The presenter should select a small number of key genes and explain them in terms of what they do in the cell.

How many genes should I highlight in a presentation to a non-specialist audience?

Three to five genes is usually enough. These should be the genes that are most important to the biological story and that have the clearest connection to the original question. The full list of differentially expressed genes can be mentioned as available in the supplementary materials.

Should I show the quality control metrics in my presentation?

Quality control metrics are important for the methods section of a paper, but they are usually not needed in a presentation to a non-specialist audience. If the audience includes people who will evaluate the technical quality of the work, such as a thesis committee, a brief mention of quality control is appropriate. Otherwise, keep the focus on the biological results.

How do I handle questions about genes I did not highlight?

Be honest and direct. If you know the answer, give it briefly. If you do not know, say so and offer to follow up after the presentation. It is better to admit uncertainty than to guess. The audience will respect honesty more than a confident but wrong answer.

What should I do if my results are negative or inconclusive?

Negative results are still results. State clearly what was tested and what was found. Explain what the negative result means for the biological question and what the next steps might be. A well-presented negative result is more valuable than a confusing positive result that cannot be reproduced.

How do I present RNA-seq data to a farmer or animal owner?

Focus on the practical question that motivated the research. Explain what the research was trying to find out and what it found in terms of animal health or production. Use analogies

Using the Evidence

Related Articles

• Single Cell Rna Seq Data Set
• Gene Set Enrichment Analysis for RNA-seq: Choosing and Interpreting Results
• Gsea Rna Seq
• Is Rna Seq Transcriptomics
• Novogene Rna Seq

References and Further Reading

• Research Methods Resources. National Library of Medicine.
• EQUATOR Network. EQUATOR Network.
• Core Practices. Committee on Publication Ethics.
• NIH Grants and Funding. National Institutes of Health.
• ORCID for Researchers. ORCID.
• Data Management and Sharing Policy. National Institutes of Health.
• NCBI Literature Resources. National Center for Biotechnology Information.
• PubMed. National Library of Medicine.

This article is educational and does not replace institutional policy, professional advice, or applicable safety and regulatory requirements.